OrbiMed Advisors LLC
- SEC CIK
- 0001055951
- Latest filing
- Aug 14, 2026
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 14, 2022. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 158
- −9 vs. Q3 2021
- Portfolio value
- $7.71B
- −$1.31B (−14.5%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| Owlet, Inc.69120X115 | EQUITY WRT | 220,704 | $86.0K | <0.1% | +220,704 | New | – |
| AUGXAugmedix, Inc. | COM | 88,363 | $278.0K | <0.1% | +88,363 | New | History |
| LBPHLongboard Pharmaceuticals, Inc. | COM | 113,500 | $554.0K | <0.1% | 00.0% | Unchanged | History |
| CABACabaletta Bio, Inc. | COM | 302,509 | $1.15M | <0.1% | 00.0% | Unchanged | History |
| LABPLandos Biopharma, Inc. | COM | 283,217 | $1.36M | <0.1% | 00.0% | Unchanged | History |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 143,640 | $1.58M | <0.1% | +143,640 | New | History |
| GYREGyre Therapeutics, Inc. | COM NEW | 1,729,402 | $1.58M | <0.1% | −982,198−36.2% | Reduced | History |
| APTXAptinyx Inc. | COM | 749,500 | $2.00M | <0.1% | +596,215+389.0% | Added | History |
| ADAGAdagene Inc. | ADS | 263,176 | $2.12M | <0.1% | −11,824−4.3% | Reduced | History |
| DRUGBright Minds Biosciences Inc. | COM | 660,600 | $2.13M | <0.1% | +660,600 | New | History |
| Aslan Pharmaceuticals Ltd04522R101 | ADS | 1,970,000 | $2.21M | <0.1% | 00.0% | Unchanged | – |
| SURFSurface Oncology, Inc. | COM | 467,945 | $2.24M | <0.1% | −441,721−48.6% | Reduced | History |
| Exscientia PLC30223G102 | ADS | 125,000 | $2.47M | <0.1% | +125,000 | New | – |
| WHWKWhitehawk Therapeutics, Inc. | COM | 127,600 | $3.08M | <0.1% | −218,662−63.1% | Reduced | History |
| XFORX4 Pharmaceuticals, Inc | COM | 1,373,849 | $3.15M | <0.1% | 00.0% | Unchanged | History |
| SGHTSight Sciences, Inc. | COM | 200,000 | $3.51M | <0.1% | 00.0% | Unchanged | History |
| INZYInozyme Pharma, Inc. | COM | 526,600 | $3.59M | <0.1% | +232,600+79.1% | Added | History |
| Field Trip Health Ord31656R102 | COM | 1,538,470 | $3.72M | <0.1% | 00.0% | Unchanged | – |
| TRMLTourmaline Bio, Inc. | COM | 247,240 | $3.78M | <0.1% | 00.0% | Unchanged | History |
| IFRXInflaRx N.V. | COM | 875,297 | $4.17M | 0.1% | −188,821−17.7% | Reduced | History |
| ALXOAlx Oncology Holdings Inc | COM | 207,600 | $4.46M | 0.1% | +57,600+38.4% | Added | History |
| HLSQTessera Defense & Homeland Security Inc. | COM | 2,813,489 | $4.50M | 0.1% | 00.0% | Unchanged | History |
| IPSCCentury Therapeutics, Inc. | COM | 307,047 | $4.87M | 0.1% | −100,000−24.6% | Reduced | History |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 500,000 | $5.04M | 0.1% | 00.0% | Unchanged | History |
| NBPNovaBridge Biosciences | SPONSORED ADS | 111,120 | $5.27M | 0.1% | 00.0% | Unchanged | History |
| SRPTSarepta Therapeutics, Inc. | COM | 58,700 | $5.29M | 0.1% | −6,000−9.3% | Reduced | History |
| NRIXNurix Therapeutics, Inc. | COM | 184,468 | $5.34M | 0.1% | −394,115−68.1% | Reduced | History |
| TARAProtara Therapeutics, Inc. | COM STK | 830,641 | $5.61M | 0.1% | +380,641+84.6% | Added | History |
| SYRSSyros Pharmaceuticals, Inc. | COM | 1,837,500 | $5.99M | 0.1% | 00.0% | Unchanged | History |
| NTLAIntellia Therapeutics, Inc. | COM | 53,200 | $6.29M | 0.1% | 00.0% | Unchanged | History |
| JBIOJade Biosciences, Inc. | COM | 535,714 | $6.32M | 0.1% | 00.0% | Unchanged | History |
| Nanostring Technologies Inc63009RAD1 | NOTE 2.625% 5/0 | – | $7.17M | 0.1% | – | – | – |
| NAUTNautilus Biotechnology, Inc. | COM | 1,452,774 | $7.53M | 0.1% | 00.0% | Unchanged | History |
| IMDXInsight Molecular Diagnostics Inc. | COM | 3,493,800 | $7.58M | 0.1% | +637,800+22.3% | Added | History |
| CALCCalciMedica, Inc. | COM SHS | 4,163,347 | $7.62M | 0.1% | 00.0% | Unchanged | History |
| GOSSGossamer Bio, Inc. | COM | 683,000 | $7.72M | 0.1% | +683,000 | New | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 1,584,845 | $7.94M | 0.1% | 00.0% | Unchanged | – |
| RAPTRAPT Therapeutics, Inc. | COM | 217,000 | $7.97M | 0.1% | +217,000 | New | History |
| CVRXCVRx, Inc. | COM | 723,055 | $8.84M | 0.1% | −76,806−9.6% | Reduced | History |
| AFIBAcutus Medical, Inc. | COM | 2,648,386 | $9.03M | 0.1% | 00.0% | Unchanged | History |
| VORVor Biopharma Inc. | COM | 833,333 | $9.68M | 0.1% | 00.0% | Unchanged | History |
| ELVNEnliven Therapeutics, Inc. | COM | 4,386,568 | $9.87M | 0.1% | 00.0% | Unchanged | History |
| RXDXPrometheus Biosciences, Inc. | COM | 250,000 | $9.88M | 0.1% | 00.0% | Unchanged | History |
| DNTHDianthus Therapeutics, Inc. | COM | 2,250,953 | $9.97M | 0.1% | +358,000+18.9% | Added | History |
| NMTR9 Meters Biopharma, Inc. | COM | 10,275,887 | $10.1M | 0.1% | +1,709,913+20.0% | Added | History |
| SONXSonendo, Inc. | COM | 1,968,180 | $11.3M | 0.1% | +1,968,180 | New | History |
| Bellus Health Inc New07987C204 | COM NEW | 1,454,800 | $11.7M | 0.2% | −1,000,000−40.7% | Reduced | – |
| QUREuniQure N.V. | SHS | 585,574 | $12.1M | 0.2% | 00.0% | Unchanged | History |
| DMRADamora Therapeutics, Inc. | COM | 4,090,937 | $12.4M | 0.2% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 805,041 | $12.4M | 0.2% | −341,104−29.8% | Reduced | History |
| Cybin Ord23256X100 | COM | 10,524,300 | $12.5M | 0.2% | −2,922,821−21.7% | Reduced | – |
| AMGNAmgen Inc | Stock | 57,100 | $12.8M | 0.2% | 00.0% | Unchanged | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 3,224,770 | $13.4M | 0.2% | 00.0% | Unchanged | History |
| BNRBurning Rock Biotech Ltd | SPONSORED ADS | 1,452,402 | $13.8M | 0.2% | −403,799−21.8% | Reduced | History |
| CTMXCytomX Therapeutics, Inc. | COM | 3,214,509 | $13.9M | 0.2% | +1,392,641+76.4% | Added | History |
| LUNGPulmonx Corp | COM | 435,000 | $13.9M | 0.2% | 00.0% | Unchanged | History |
| SYRESpyre Therapeutics, Inc. | COM | 2,956,124 | $14.0M | 0.2% | −1,059,400−26.4% | Reduced | History |
| ACRSAclaris Therapeutics, Inc. | COM | 985,900 | $14.3M | 0.2% | +334,117+51.3% | Added | History |
| SYBXSynlogic, Inc. | COM | 6,029,995 | $14.6M | 0.2% | 00.0% | Unchanged | History |
| LABStandard Biotools Inc. | COM | 3,819,348 | $15.0M | 0.2% | −780,223−17.0% | Reduced | History |
| RXSTRxSight, Inc. | COM | 1,383,500 | $15.6M | 0.2% | +133,500+10.7% | Added | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 406,100 | $15.7M | 0.2% | −8,200−2.0% | Reduced | History |
| NXTCNextCure, Inc. | COM | 2,711,013 | $16.3M | 0.2% | 00.0% | Unchanged | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 6,943,654 | $16.7M | 0.2% | 00.0% | Unchanged | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 2,583,821 | $16.9M | 0.2% | 00.0% | Unchanged | History |
| IRONDisc Medicine, Inc. | COM | 5,826,224 | $17.0M | 0.2% | 00.0% | Unchanged | History |
| ILMNIllumina, Inc. | COM | 45,100 | $17.2M | 0.2% | +45,100 | New | History |
| CRISCuris Inc | COM NEW | 3,634,800 | $17.3M | 0.2% | +113,400+3.2% | Added | History |
| Danaher Corp235851409 | 5% CONV PFD B | – | $17.4M | 0.2% | – | New | – |
| CMMBChemomab Therapeutics Ltd. | SPONSORED ADS | 2,578,174 | $17.8M | 0.2% | 00.0% | Unchanged | History |
| MRSNMersana Therapeutics, Inc. | COM | 2,888,847 | $18.0M | 0.2% | 00.0% | Unchanged | History |
| LENZLENZ Therapeutics, Inc. | COM | 1,565,812 | $19.5M | 0.3% | +115,908+8.0% | Added | History |
| LogicBio Therapeutics, Inc.54142F102 | COM | 8,466,783 | $19.6M | 0.3% | 00.0% | Unchanged | – |
| XENEXenon Pharmaceuticals Inc. | COM | 631,000 | $19.7M | 0.3% | +154,000+32.3% | Added | History |
| APLTApplied Therapeutics, Inc. | COM | 2,313,681 | $20.7M | 0.3% | +56,294+2.5% | Added | History |
| GILDGilead Sciences, Inc. | Stock | 287,600 | $20.9M | 0.3% | 00.0% | Unchanged | History |
| HARPHarpoon Therapeutics, Inc. | COM | 2,903,508 | $21.9M | 0.3% | +292,200+11.2% | Added | History |
| DBTXDecibel Therapeutics, Inc. | COM | 4,945,192 | $23.0M | 0.3% | 00.0% | Unchanged | History |
| KDNYChinook Therapeutics, Inc. | COM | 1,418,300 | $23.1M | 0.3% | −2,337−0.2% | Reduced | History |
| JNCEJounce Therapeutics, Inc. | COM | 2,859,900 | $23.9M | 0.3% | +204,300+7.7% | Added | History |
| SCPHscPharmaceuticals Inc. | COM | 4,797,148 | $24.1M | 0.3% | 00.0% | Unchanged | History |
| OMICSingular Genomics Systems, Inc. | COM | 2,104,359 | $24.3M | 0.3% | +105,838+5.3% | Added | History |
| THCTenet Healthcare Corp | COM NEW | 299,000 | $24.4M | 0.3% | −12,700−4.1% | Reduced | History |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 12,909,283 | $25.2M | 0.3% | 00.0% | Unchanged | History |
| VTYXVentyx Biosciences, Inc. | COM | 1,289,280 | $25.6M | 0.3% | +1,289,280 | New | History |
| Vectivbio Hldg AGH9060V101 | ORD SHS | 5,223,804 | $25.6M | 0.3% | +100,500+2.0% | Added | – |
| EVHEvolent Health, Inc. | CL A | 938,000 | $26.0M | 0.3% | +593,000+171.9% | Added | History |
| ERASErasca, Inc. | COM | 1,667,693 | $26.0M | 0.3% | −499,648−23.1% | Reduced | History |
| PCVXVaxcyte, Inc. | COM | 1,096,700 | $26.1M | 0.3% | +62,035+6.0% | Added | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 3,791,204 | $26.8M | 0.3% | 00.0% | Unchanged | History |
| MREOMereo BioPharma Group plc | SPON ADS | – | $27.6M | 0.4% | – | – | History |
| IMGNImmunoGen, Inc. | COM | 3,868,786 | $28.7M | 0.4% | −11,029,128−74.0% | Reduced | History |
| CTKBCytek Biosciences, Inc. | COM | 1,923,139 | $31.4M | 0.4% | 00.0% | Unchanged | History |
| SRRASierra Oncology, Inc. | COM NEW | 1,477,320 | $32.1M | 0.4% | 00.0% | Unchanged | History |
| GHRSGH Research PLC | ORDINARY SHARES | 1,428,732 | $33.3M | 0.4% | +660.0% | Added | History |
| NSTGNS Wind Down Co., Inc. | COM | 807,100 | $34.1M | 0.4% | +251,100+45.2% | Added | History |
| ORICOric Pharmaceuticals, Inc. | COM | 2,337,574 | $34.4M | 0.4% | 00.0% | Unchanged | History |
| IVVDInvivyd, Inc. | COM | 4,983,500 | $36.2M | 0.5% | −400,000−7.4% | Reduced | History |
| SEMSelect Medical Holdings Corp | COM | 1,233,600 | $36.3M | 0.5% | −37,500−3.0% | Reduced | History |
| IMAImageneBio, Inc. | COM | 2,933,941 | $36.8M | 0.5% | 00.0% | Unchanged | History |
Sold out since Q3 2021 (23)
Positions held at the end of Q3 2021 that are gone from this filing.
| Security | Class | Shares in Q3 2021 | Value in Q3 2021 | % of portfolio in Q3 2021 | History |
|---|---|---|---|---|---|
| ELVElevance Health, Inc. | Stock | 207,100 | $77.2M | 0.9% | History |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 2,183,143 | $74.2M | 0.8% | History |
| PGNYProgyny, Inc. | COM | 1,270,045 | $71.1M | 0.8% | History |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 612,700 | $68.6M | 0.8% | History |
| OLMAOlema Pharmaceuticals, Inc. | COM | 807,792 | $22.3M | 0.2% | History |
| CTICCti Biopharma Corp | COM | 7,520,600 | $22.2M | 0.2% | History |
| VRCAVerrica Pharmaceuticals Inc. | COM | 1,479,733 | $18.5M | 0.2% | History |
| HUMAHumacyte, Inc. | COM | 1,500,000 | $17.4M | 0.2% | History |
| FLXNFlexion Therapeutics Inc | COM | 2,769,383 | $16.9M | 0.2% | History |
| DICEDICE Therapeutics, Inc. | COM | 440,000 | $14.4M | 0.2% | History |
| MAPSWM Technology, Inc. | COM | 700,400 | $10.2M | 0.1% | History |
| KZRKezar Life Sciences, Inc. | COM | 1,150,000 | $9.94M | 0.1% | History |
| NVAXNovavax Inc | COM NEW | 45,580 | $9.45M | 0.1% | History |
| KALAKALA BIO, Inc. | COM | 3,438,998 | $9.01M | 0.1% | History |
| CNVYConvey Health Solutions Holdings, Inc. | COM | 1,000,000 | $8.40M | 0.1% | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 13,560 | $8.21M | 0.1% | History |
| OWLTOwlet, Inc. | COMMON STOCK | 1,200,000 | $6.71M | 0.1% | History |
| NBTXNanobiotix S.A. | SPONSORED ADS | 500,000 | $5.68M | 0.1% | History |
| APTOAptose Biosciences Inc. | COM NEW | 2,594,348 | $5.66M | 0.1% | History |
| PRCTPROCEPT BioRobotics Corp | COM | 135,000 | $5.15M | 0.1% | History |
| RGENRepligen Corp | COM | 14,724 | $4.25M | <0.1% | History |
| SBBPStrongbridge Biopharma plc | SHS USD | 794,675 | $1.62M | <0.1% | History |
| PHASPhaseBio Pharmaceuticals Inc | COM | 177,113 | $551.0K | <0.1% | History |